TEL AVIV, September 17 /PRNewswire/ --

- RADWIN's MPTP Systems Transmit VoIP, Data, E-Ticketing & Video Surveillance Information with High-Capacity and Long Range

RADWIN (http://www.radwin.com), a leading provider of wireless broadband solutions, announced that Kenya Wildlife Service (KWS) has deployed its systems in eight national parks. KWS is in charge of Kenya's national parks, and has deployed RADWIN's Multiple point-to-point (MPtP) systems to connect its headquarters in Nairobi to a number of parks. UUNET Kenya and Adwest were in charge of project deployment.

LONDON, September 17 /PRNewswire/ --

- Review the Site at: http://www.mariestopes.org.uk/sexbomb

Marie Stopes International (MSI), the UK's leading sexual health agency, today launches its Sex Bomb campaign to discover what sex and relationships mean to Britons in this first decade of the 21st century.

LONDON, September 17 /PRNewswire/ -- VocaLink, the payment transaction specialist, today announced that it had signed a partnership agreement with Axway, a leading provider of collaborative business solutions. Under the agreement Axway will provide a gateway for VocaLink's clients to access its Euro services and other VocaLink services.

Axway has developed a very cost-effective thin client gateway, which is downloadable from the internet. This will enable VocaLink to extend its Euro services offering in a cost-effective way and make it an attractive proposition for even smaller users.

GENEVA, Switzerland, September 17 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that patient enrollment has been completed in the REFLEX trial (REbif FLEXible dosing in early multiple sclerosis). This randomized, double-blind, placebo-controlled, international Phase III trial is designed to evaluate the therapeutic benefit of Rebif(R) (interferon beta-1a) on the time to conversion to multiple sclerosis (MS) in people with a first clinical event suggestive of the disease.

LONDON, September 17 /PRNewswire/ --

- With Photo

NEW YORK and LONDON, September 16 /PRNewswire/ --

- Named Patient Programmes Yield ROI, Additional Benefits for Pharmaceutical Organizations

Eularis today announced the release of a first-ever study on the ROI of named patient programmes (NPP), also known as compassionate use programs. The paper, "Implementing a pre-launch named patient programme -- evidence of increased market share," provides pharmaceutical companies with insight and mathematical justification into the cash market share and revenue impact of pre-launch NPPs on brands, while outlining the benefits and challenges that they create.